Jermyn Michael, Desroches Joannie, Mercier Jeanne, St-Arnaud Karl, Guiot Marie-Christine, Leblond Frederic, Petrecca Kevin
Thayer School of Engineering, Dartmouth College, 14 Engineering Dr., Hanover, NH 03755, USA; Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, 3801 University St., Montreal, QC, H3A 2B4, Canada; Dept. of Engineering Physics, Polytechnique Montreal, CP 6079, Succ. Centre-Ville, Montreal, QC, H3C 3A7, Canada.
Dept. of Engineering Physics, Polytechnique Montreal, CP 6079, Succ. Centre-Ville, Montreal, QC, H3C 3A7, Canada.
Biomed Opt Express. 2016 Nov 16;7(12):5129-5137. doi: 10.1364/BOE.7.005129. eCollection 2016 Dec 1.
Surgical treatment of brain cancer is limited by the inability of current imaging capabilities such as magnetic resonance imaging (MRI) to detect the entirety of this locally invasive cancer. This results in residual cancer cells remaining following surgery, leading to recurrence and death. We demonstrate that intraoperative Raman spectroscopy can detect invasive cancer cells centimeters beyond pathological T1-contrast-enhanced and T2-weighted MRI signals. This intraoperative optical guide can be used to detect invasive cancer cells and minimize post-surgical cancer burden. The detection of distant invasive cancer cells beyond MRI signal has the potential to increase the effectiveness of surgery and directly lengthen patient survival.
脑癌的外科治疗受到当前成像技术(如磁共振成像(MRI))的限制,这些技术无法检测到这种局部浸润性癌症的全部范围。这导致手术后残留癌细胞,进而导致复发和死亡。我们证明,术中拉曼光谱能够检测到距离病理T1加权增强和T2加权MRI信号数厘米远的浸润癌细胞。这种术中光学引导可用于检测浸润癌细胞,并将术后癌症负担降至最低。检测超出MRI信号范围的远处浸润癌细胞有可能提高手术效果并直接延长患者生存期。